EyePoint (NASDAQ: EYPT) revenue
EyePoint reported revenue of $31.4m for fiscal 2025, 27.5% less than in fiscal 2024 ($43.3m). Since fiscal 2016 its revenue has grown by 1,836.5%, an average growth of 34.5% a year.
EyePoint's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2025, −27.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $31.4m | −27.5% | −$243.4m | −776.0% |
| 2024 | $43.3m | −6.0% | −$145.9m | −337.1% |
| 2023 | $46.0m | +11.1% | −$75.1m | −163.1% |
| 2022 | $41.4m | +12.1% | −$99.6m | −240.6% |
| 2021 | $36.9m | +7.3% | −$55.3m | −149.6% |
| 2020 | $34.4m | +69.1% | −$37.3m | −108.3% |
| 2019 | $20.4m | +345.5% | −$47.9m | −235.0% |
| 2018 | $4.6m | — | −$39.0m | −853.6% |
| 2017 | $7.5m | +365.4% | −$18.6m | −246.4% |
| 2016 | $1.6m | — | −$21.8m | −1,344.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
EyePoint revenue compared with its sector
By revenue for its latest fiscal year, EyePoint ranks 349th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; EyePoint, −27.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 347th | Orchestra BioMed | $33.5m | 1,169.2% |
| 348th | Stereotaxis | $32.4m | 20.3% |
| 349th | EyePoint | $31.4m | −27.5% |
| 350th | Verastem | $30.9m | 209.1% |
| 351st | Foghorn Therapeutics | $30.9m | 36.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of EyePoint
- How much revenue did EyePoint make in fiscal 2025?
- EyePoint reported revenue of $31.4m for fiscal 2025, compared with $43.3m in fiscal 2024.
- How much has the revenue of EyePoint grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.6m to $31.4m: 1,836.5% more, an average growth of 34.5% a year.
- What was the best year for revenue at EyePoint?
- Of its last 10 fiscal years, fiscal 2023, with $46.0m.
- Where does EyePoint rank in its sector by revenue?
- It ranks 349th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for EyePoint come from?
- From the annual report (Form 10-K) that EyePoint files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that EyePoint files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on EyePoint: the EyePoint page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.